BMS-986004: Clinical Trials

1 trial of BMS-986004, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow BMS-986004: new trials by email Literature Review of BMS-986004 trials Research Report on BMS-986004

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease
BMS-986004, Sirolimus, Tacrolimus - Graft-versus-host-disease, GVHD
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute452019-02-152026-04-02

Conditions studied

Graft vs Host Disease (1)

Sponsors

H. Lee Moffitt Cancer Center and Research Institute (1)

Countries

United States (1)

Top investigators

Farhad Khimani, M.D. (1)